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Abstract
Mutation provides the ultimate source of all new alleles in populations, including variants that cause disease and fuel
adaptation. Recent whole genome sequencing studies have uncovered variation in the mutation rate among individuals
and differences in the relative frequency of specific nucleotide changes (the mutation spectrum) between populations.
Although parental age is a major driver of differences in overall mutation rate among individuals, the causes of variation
in the mutation spectrum remain less well understood. Here, I use high-quality whole genome sequences from 29 inbred
laboratory mouse strains to explore the root causes of strain variation in the mutation spectrum. My analysis leverages
the unique, mosaic patterns of genetic relatedness among inbredmouse strains to identify strain private variants residing
on haplotypes shared between multiple strains due to their recent descent from a common ancestor. I show that these
strain-private alleles are strongly enriched for recent de novo mutations and lack signals of widespread purifying selec-
tion, suggesting their faithful recapitulation of the spontaneous mutation landscape in single strains. The spectrum of
strain-private variants varies significantly among inbred mouse strains reared under standardized laboratory conditions.
This variation is not solely explained by strain differences in age at reproduction, raising the possibility that segregating
genetic differences affect the constellation of newmutations that arise in a given strain. Collectively, these findings imply
the action of remarkably precise nucleotide-specific genetic mechanisms for tuning the de novo mutation landscape in
mammals and underscore the genetic complexity of mutation rate control.
Key words: house mice, germline mutation, mutation spectrum.
Introduction
The de novo mutation rate determines the frequency at
which new alleles arise in populations, with the potential
for such variants to drive adaptive evolution or cause disease.
Knowledge of this fundamental quantity is critical for inter-
preting levels of neutral diversity in populations (Kimura
1983), dating historical events from genetic data (Scally and
Durbin 2012; Moorjani et al. 2016), and forecasting the ulti-
mate fate of a species (Lynch 2016). De novo mutation rates
also determine the incidence of many rare Mendelian diseases
(Kondrashov 2003) and influence genetic risk for multiple
common diseases (Vissers et al. 2010; Girard et al. 2011;
O’Roak et al. 2011, 2012; Xu et al. 2011; Iossifov et al. 2012;
Neale et al. 2012; Sanders et al. 2012; Bomba et al. 2017).
Despite its critical importance to human health and evo-
lution, the rate of mutation exhibits considerable variability.
Mutation rates fluctuate across genomes (Hodgkinson and
Eyre-Walker 2011; Segurel et al. 2014), conditional on aspects
of the local chromatin environment (Schuster-Bo¨ckler and
Lehner 2012; Chen et al. 2017; Carlson et al. 2018), recombi-
nation rate (Lercher and Hurst 2002; Hardison et al. 2003;
Besenbacher et al. 2016), GC content (Hardison et al. 2003;
Schaibley et al. 2013), DNA replication timing
(Stamatoyannopoulos et al. 2009; Francioli et al. 2015), tran-
scription (McVicker and Green 2010; Park et al. 2012; Chen
et al. 2017), and flanking nucleotide context (Duncan and
Miller 1980; Hwang and Green 2004; Carlson et al. 2018).
The mutation rate varies by orders of magnitude between
species (Uchimura et al. 2015; Smeds et al. 2016; Senra et al.
2018), presumably reflecting species differences in DNA repair
mechanisms (Hart and Setlow 1974; MacRae et al. 2015),
metabolism (Martin and Palumbi 1993), and life history
(Nabholz et al. 2008). There are striking mutation rate differ-
ences among individuals, including a marked dimorphism
between males and females and a pronounced age effect
(Crow 2000; Conrad et al. 2011; Kong et al. 2012; O’Roak
et al. 2012; Francioli et al. 2015; Besenbacher et al. 2016;
Jonsson et al. 2017). Population genomic analyses even point
to differences in the mutation spectrum—the relative frac-
tion of de novo mutations that result in particular types of
nucleotide changes—among individuals (Harris 2015; Assaf
et al. 2017; Harris and Pritchard 2017; Mathieson and Reich
2017). Thus, a subset of individuals in a population dispro-
portionately contributes to the pool of new mutations that
arise each generation, and different individuals are more
prone to transmitting particular types of single nucleotide
mutations to their offspring.
While differences in parental age at reproduction may ac-
count for much of the observed variation in human germline
mutation rates (Kong et al. 2012; Jonsson et al. 2017),
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environmental and genetic factors likely also play a role.
Exposure to ionizing radiation (Dubrova, Bersimbaev, et al.
2002; Dubrova, Grant, et al. 2002), cigarette smoke (Zenzes
2000; Shi et al. 2001; DeMarini 2004), caffeine (Robbins, Vine,
et al. 1997), and chemotherapeutic agents (Robbins,
Meistrich, et al. 1997; Frias et al. 2003) have been previously
associated with increased germline mutation loads in
humans. Differences in exposures among individuals could
contribute to observed mutation rate variation. In addition,
there are >1,000 genes in the mammalian genome with an-
notated functions in DNA damage surveillance, DNA repair,
and the metabolism of genotoxic compounds (Carbon et al.
2009). These loci represent potential reservoirs of functional
genetic variation modifying the fidelity and efficiency of DNA
damage repair and tuning genomic sensitivity to mutagens
(Baer et al. 2007). Consistent with this possibility, mutations
in DNA repair genes have been associated with elevated so-
matic mutation rates (Ahn et al. 2016), increased cancer risk
(Easton et al. 2007; Dowty et al. 2013), and premature aging
(de Boer et al. 2002; Lombard et al. 2005). Despite the con-
siderable functional overlap of the DNA proofreading and
repair machinery between the soma and the germline, there
have been few efforts to directly link variation at putative
modifier loci to variation in germline mutation rates in mam-
mals (Uchimura et al. 2015; Seoighe and Scally 2017).
Comparative genomic analyses of cancer tumors and con-
trol tissues have uncovered remarkably precise, sequence-
dependent mechanisms of mutation. Defects in specific
DNA repair genes and pathways can result in distinct somatic
mutation signatures, defined by the relative enrichment of
mutation events in specific nucleotide contexts (Nik-Zainal
et al. 2012; Alexandrov et al. 2013; Helleday et al. 2014). For
example, altered activity of the error prone polymerase Pol is
associated with 50-TCT-30>50-TAT-30 and 50-TTT-30>50-
TGT-30 mutations in human cancers (Cancer Genome
Atlas Network 2012; Alexandrov et al. 2013; Cancer
Genome Atlas Research Network 2013; Shinbrot et al.
2014). Cancers with altered AID/APOBEC mutational activity
are characterized by a preponderance of 50-TCA-30>50-TTA-
30 mutations (Nik-Zainal et al. 2012; Alexandrov et al. 2013).
Such observations raise the possibility that segregating poly-
morphisms in DNA repair genes could also influence germline
mutation rates with extraordinary sequence context preci-
sion. Indeed, there are significant differences in the human
germline mutation spectrum inferred from population-
private (Harris 2015), rare (Mathieson and Reich 2017), and
derived alleles (Harris and Pritchard 2017). However, the chal-
lenge of disentangling variable parental age, differential envi-
ronmental exposures, and genetic differences between
human populations makes it difficult to address the under-
lying causes of observed variation in the mutation spectrum
in our own species.
The availability of high-quality genomes from multiple in-
bred laboratory mouse strains provides a powerful opportu-
nity to overcome this limitation (Keane et al. 2011; Adams
et al. 2015). As a consequence of their unique historical origins
from a small founder population (Wade and Daly 2005; Yang
et al. 2007, 2011), variants that are private to single inbred
mouse strains but that reside on haplotypes that are other-
wise shared between strains have likely arisen de novo since
their inception as laboratory models. I leverage this recogni-
tion to derive the germline mutation spectrum in 29 com-
mon inbred mouse strains. I document significant differences
in the mutation spectrum between mouse strains reared in
standard laboratory environments and show that this varia-
tion is not solely accounted for by differences in strain age at
breeding. My findings suggest that multiple modifiers of the
mutation spectrum segregate among inbred mouse strains,
implying that the process of germline mutation is itself a
complex genetic trait.
Results and Discussion
Identification of Recent, Spontaneous Mutations in
Laboratory Mice
The classical laboratory mouse strains derive from a small,
ancestral population of wild founder animals that were selec-
tively bred for traits of interest by mouse fanciers in the late
19th and early 20th centuries. As a consequence of their
unique historical origins, the genetic diversity captured in
laboratory mice represents an extremely limited sample of
the diversity found in wild mouse populations (Salcedo et al.
2007; Yang et al. 2011; Phifer-Rixey and Nachman 2015).
Notably, variation among inbred strains at over 97% of the
genome can be reconciled into fewer than ten distinct hap-
lotypes (Yang et al. 2011). Thus, the genomes of the labora-
tory strains can be envisioned as mosaics derived from this
small founder pool, with the haplotype of a given genomic
region in one strain likely shared between multiple strains
(fig. 1).
Although the majority of genetic variants segregating
among the inbred laboratory strains trace to variation in
this “Fancy Mouse” founder population, a small remaining
number of sites can be attributed to recent de novo muta-
tions that occurred following their inception as laboratory
models. Many inbred strains carry known spontaneous muta-
tions that drifted to fixation in inbreeding colonies. For ex-
ample, a de novo mutation on the C57BL/6N background
generated a missense mutation in cytoplasmic FMRP interact-
ing protein 2 (Cflip2) that confers a sensitized response to
cocaine (Kumar et al. 2013). Similarly, a spontaneous muta-
tion in Tlr4 in C3H/HeJ mice renders this strain uniquely
resistant to endotoxin (Qureshi et al. 1999).
One strategy for systematically identifying these recent,
spontaneous mutations is to identify alleles that are private
to a single laboratory mouse strain, but that reside on a hap-
lotype that is otherwise identical by descent (IBD) in multiple
strains (fig. 1). A conceptually similar approach has been pre-
viously used to identify de novo mutations in large, multi-
generational human pedigrees (Campbell et al. 2012;
Palamara et al. 2015; Narasimhan et al. 2017). To this end, I
used publicly available high-quality whole-genome sequences
from 29 inbred mouse strains to identify autosomal IBD
regions 5 Mb shared between at least 2 strains (Keane
et al. 2011; Adams et al. 2015; see Materials and Methods).
On an average, 46.8% of the genome of a given inbred strain is
Dumont . doi:10.1093/molbev/msz026 MBE
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present in IBD blocks of this size (range: 6.7% KK/HiJ to 82.7%
C57BL/6NJ; supplementary table S3, Supplementary Material
online). In contrast, no IBD blocks 5 Mb are observed in a
sample of 27 wild Mus musculus domesticus genomes (sup-
plementary table S2 and fig. S1, Supplementary Material on-
line; Harr et al. 2016). These findings reinforce the close
genetic relatedness of the common laboratory strains and
confirm their origins from a very small number of founder
individuals (Beck et al. 2000; Frazer et al. 2007; Yang et al.
2011).
I next identified 15,311 strain private variants (SPVs) on
large (5 Mb) IBD blocks (fig. 1; see Materials and Methods).
Approximately 91.7% of these SPVs are fixed for the alterna-
tive allele, with the remaining 8.3% present in a heterozygous
state. On an average, there are 528 SPVs per strain (Range: 103
in KK/HlJ to 1,028 C57BR/cdJ; supplementary tables S3 and
S4, Supplementary Material online), with the number of SPVs
strongly correlated with the fraction of a given strain’s ge-
nome captured in IBD regions (Spearman’s Rho ¼ 0.824;
P¼ 4.0108). Given the absence of IBD blocks 5 Mb in
wild mouse populations (supplementary table S2 and fig. S1,
Supplementary Material online), these SPVs are almost cer-
tainly due to recent mutations, as opposed to variants inher-
ited from wild mouse ancestral populations.
Strain Private Variants Approximate Neutral
Expectations
The maintenance of inbred strains via small “foundation
stocks” of sister-brother mating pairs approximates the ex-
perimental design of a mutation accumulation experiment
and minimizes the efficacy of natural selection at each
generation (Currer et al. 2009). Consequently, the vast major-
ity of new mutations that arise during strain propagation are
expected to be effectively neutral and their ultimate fate will
be governed by chance (Eyre-Walker and Keightley 2007).
Only a small subset of these neutral mutations will drift to
fixation within an inbreeding colony, but those that do fix
should be a representative, random sample of all neutral
mutations. In contrast, a small number of new mutations
are expected to be deleterious, and even fewer will confer
an adaptive advantage. Although nonneutral mutations will
be subject to selection or go unrealized due to viability defects
or infertility, such large-effect variants should comprise a small
fraction of all new mutations (Eyre-Walker and Keightley
2007; Uchimura et al. 2015). Based on these considerations,
I reasoned that the set of SPVs for a given strain should ap-
proximate the strain-specific distribution of germline
mutations.
To confirm the interpretation of observed SPVs as re-
cent de novo mutations that have not been strongly bi-
ased by natural selection, I took advantage of expected
differences in signals of historical selection at young ver-
sus old mutations. Mutations that have arisen recently in
the laboratory strains have not been segregating for am-
ple time to bear strong signatures of past selection. As a
result, new mutations should be approximately randomly
distributed within functional genomic regions. In con-
trast, old ancestral variants have been subject to gener-
ations of purifying selection and should be depleted for
functional variants. I tested these dueling predictions us-
ing two approaches.
First, I determined the fraction of coding SPVs that result in
synonymous and nonsynonymous changes. Assuming a
FIG. 1. Schematic of the approach used to identify putative de novo mutations in inbred laboratory mouse strains. The genomes of laboratory mice
can be envisaged as mosaics of less than ten haplotypes derived from a small population of founder animals. The ancestral haplotype structure of
four strains is illustrated, with unique haplotypes depicted in different colors. Given the small number of founders, multiple strains are likely to
share the same haplotype at a given locus by virtue of their descent from a common ancestor. An example of one such region shared by three of the
four depicted strains (light blue haplotype) is outlined by dashed lines. Recent mutations that arose in a single focal strain can be detected as strain-
private variants resident on haplotypes that are shared identical-by-descent between strains.
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uniform probability of mutation at all amino acid encoding
sites, 72.2% and 3.8% of spontaneous mutations should result
in missense and nonsense changes, respectively (Assaf et al.
2017). In rough agreement with these null expectations, 67.2%
and 3.4% of the coding SPVs identified on IBD haplotypes are
missense and nonsense substitutions, respectively (table 1).
This represents a significant enrichment for potentially
functional protein-coding variation relative to common
variants segregating in 2 mouse strains (G-test,
P¼ 8.221060; table 1). The observed deficit of nonsy-
nonymous substitutions relative to the expected 72.2%
may be explained by selection against mutations that
confer lethality, infertility, or alter stereotyped strain phe-
notypes. Importantly, these bulk trends are broadly reca-
pitulated on a per strain basis: the frequencies of
missense, nonsense, and synonymous SPVs within coding
regions do not significantly differ from null expectations
for 27 of the 29 inbred strains (G-test of independence,
P> 0.05; supplementary table S5 and fig. S2,
Supplementary Material online). Although power to de-
tect a significant departure from the null expectation is
low given the small number of coding variants per strain,
these findings provide no reason to suspect that the
strength of selection against deleterious mutations differs
markedly among strains.
Second, I compared the distribution of sequence conser-
vation scores between common and strain-private variants.
Sites that are well conserved across species are typically inter-
preted as targets of purifying selection to maintain a critical
biological function (Siepel et al. 2005). Mutations at these sites
are expected to be more deleterious, on an average, than
those that arise in poorly conserved (and presumably non-
functional) regions. As a result, evolutionarily conserved sites
should be depleted for older, intermediate frequency variants.
On the other hand, recent de novo mutations have not yet
been strongly shaped by selection, and their genomic distri-
bution should approximate the genome-wide distribution of
sequence conservation scores. Consistent with their hypoth-
esized origins from recent mutations, SPVs are enriched in
conserved genomic regions compared with common variants
(Kolmogorov–Smirnov test P< 2.21016), and closely ap-
proximate the cumulative distribution of sequence conserva-
tion scores across the mouse reference genome (fig. 2). This
overall finding is also preserved on a per-strain basis; for all
strains, the distribution of sequence conservation scores at
SPVs is skewed toward conserved sites relative to common
variants (supplementary fig. S3, Supplementary Material
online).
The striking enrichment of SPVs in functional coding
regions and conserved sequences relative to common var-
iants is consistent with their recent emergence in the labora-
tory strains. These findings suggest that few ancestral alleles
are masquerading as SPVs in this data set and reveal the
absence of pervasive, strong selection against new mutations
in laboratory colonies. Taken together, these results indicate
that the set of SPVs for a focal inbred laboratory strain
approximates the cumulative action of diverse germline mu-
tational processes active in that strain.
The Spectrum of Strain-Specific Variants in Inbred
House Mice
The most parsimonious interpretation for a SPV on an IBD
haplotype is that it arose from a single mutational event
during the focal strain’s breeding history. For example, if all
classical laboratory strains have a “G” allele at a particular site,
with the exception of BALB/cJ which carries a “T” allele, it can
be inferred that a G> T mutation occurred in a recent com-
mon ancestor of the BALB/cJ strain. By extending this logic
genome-wide, I identified the set of single nucleotide muta-
tions that putatively arose in each classical laboratory strain.
Using the information available from other strains, I polarized
each mutational event into likely ancestral and derived alleles
and then quantified the number of mutations in each strain
that are of each possible mutational class. To account for the
sequence dependency of mutation rates, mutation counts
were standardized by the nucleotide composition of all IBD
regions in the focal strain and scaled to sum to one. Owing to
ambiguity in the strand of origin of a particular mutation,
Table 1. Frequencies of Coding Variants as a Function of Variant
Frequency.
Common Variantsa
(%; 95% bootstrap CIb)
Strain Private Variants
(%; 95% bootstrap CIb)
Coding variants 75,509 (NA) 439 (NA)
Synonymous
variants
49,964 (66.2; 65.8–66.5) 129 (29.4; 25.1–33.7)
Missense
variants
25,303 (33.5; 33.1–33.8) 295 (67.2; 62.4–71.4)
Nonsense
variants
242 (0.32; 0.28–0.36) 15 (3.4; 1.9–5.3)
aCommon variants are defined as variants present in two or more laboratory
strains, including the C57BL/6J reference.
b95% confidence intervals are derived from 1,000 bootstrap resamples of observed
variants.
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complementary mutations were binned to produce the
folded SPV spectrum for each strain (fig. 3).
SPV spectra display qualitative similarities among mouse
strains, with relative variant frequencies following the same
rank order. For all strains, C>G, T>A, and T>G mutations
are the rarest mutational classes, with each mutation type
accounting for 2.1–11.7% of SPVs. C> T transitions are the
most frequent type of SPVs, ranging from 41.8% to 58.6% of
SPVs among strains (fig. 3 and supplementary table S3,
Supplementary Material online). This C> T fraction is nota-
bly higher than the proportion of rare human SNPs (Harris
and Pritchard 2017) and de novo mutations (Rahbari et al.
2016; Jonsson et al. 2017) that are C> T transitions (40%),
but is consistent with the elevated relative frequency of de
novo C> T mutations observed in mouse pedigrees (Lindsay
et al. 2018). Despite an overall excess of C> T SPVs, the lab-
oratory mouse strains actually exhibit a marked deficit of
CpG>TpG SPVs compared with both de novo mouse and
human mutation spectra (supplementary fig. S4,
Supplementary Material online). This discrepancy is likely at-
tributable to differences in variant ascertainment between
studies, underscoring the need for caution in comparisons
of spectra derived from SPVs and de novo mutations.
Despite this caveat, mouse SPVs recapitulate key differences
between the de novo mutation spectra of mouse and human,
including reduced T>C and increased T>A relative muta-
tion frequencies in mouse (supplementary fig. S4,
Supplementary Material online; Lindsay et al. 2018).
Although the ranked relative frequencies of different var-
iant classes exhibit broad conservation among strains, 71.7%
of the 406 possible strain pairs possess significantly distinct
SPV spectra (G-test, uncorrected P< 0.05, d.f. ¼ 5; supple-
mentary table S6, Supplementary Material online). To further
explore this variation, I performed a principle component
analysis on the nucleotide-adjusted frequencies of each mu-
tational type across the 29 classical inbred strains. Principle
component (PC) 1 isolates FVB/NJ, NOD/ShiLtJ, DBA/1J, and
NZB/BlNJ from all other strains (fig. 4). These strains are char-
acterized by an elevated relative rate of C>A mutations and
exceptionally low proportions of C>G and T>G mutations
(supplementary table S3, Supplementary Material online).
Thus, the major axis of variance in these data is dominated
by multidimensional properties of the mutation spectrum.
Strains belonging to the C57 (C57BL/10J, C57BL/6NJ, C57BR/
cdJ, C57L/J) and 129 (129P2/OlaHsd, 129S1/SvImJ, 129S5/
SvEvBrd) strain families show a loose tendency to cluster
(fig. 4), suggesting that more closely related strains have
more similar mutation spectra.
Causes of Variation in the Mutation Spectrum among
Inbred Mouse Strains
The observed strain differences in the mouse mutation spec-
trum could be driven by environmental differences, strain
variation in parental age at reproduction, or genetic factors
segregating among strains. Given that inbred strains are
reared under standardized laboratory conditions, environ-
mental contributions to strain variation in the mutation spec-
trum seem unlikely, although effects from minor differences
in animal husbandry cannot be ruled out.
There are established age-related shifts in the human de
novo mutation spectrum (Jonsson et al. 2017). Although a
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comparable effect on the mouse mutation spectrum has yet
to be shown, differences in reproductive aging between
strains could contribute to variation in the mutation spec-
trum. The inbred strains profiled here significantly differ for
two proxy measures of age at reproduction: dam age at first
litter (supplementary fig. S5, Supplementary Material online;
one-way ANOVA F15,746¼ 15.11; P< 2.21016) and average
interbirth interval (supplementary fig. S6, Supplementary
Material online; one-way ANOVA F15,2281¼ 16.29;
P< 2.21016). However, variation in these life history traits
does not fully account for observed differences in the muta-
tion spectrum. PC1, which captures 79% of the variance in the
mutation spectrum among inbred laboratory strains (fig. 4), is
not correlated with the dam age at first litter or average
interbirth interval (table 2). Similarly, with only one exception,
strain variation in the proportion of SPVs belonging to each
mutational category is not correlated with either life history
trait (table 2). The exception is a positive correlation between
the frequency of C>G mutations and interbirth interval
(table 2). Many C>G mutations are hypothesized to arise
from spontaneous double-strand break induced damage in
the germline, the frequency of which may increase with lon-
ger generation times (Jonsson et al. 2017; Gao Z, Moorjani P,
Amster G, Przeworski M, unpublished data; Agarwal I,
Przeworski M, unpublished data).
Taken together, these considerations suggest that the
spectrum of SPVs in a given strain is at least partially attrib-
utable to segregating genetic differences among strains. Strain
variation in the fraction of SPVs within each mutational class
is continuous (supplementary fig. S7, Supplementary Material
online), suggesting that the genetic control of the germline
mutation spectrum is potentially both polygenic and
complex.
Modifiers of the Mouse Mutation Spectrum
My findings raise the possibility that distinct inbred mouse
strains harbor unique suites of mutation modifying loci that
collectively exert precise, nucleotide-dependent effects on the
spectrum of accumulated de novo mutations. Determining
the molecular identity of these mutation spectrum modifiers
is an important outstanding research aim, albeit one that falls
outside the scope of this paper. Genetic differences in genes
involved in DNA repair, replication, genome surveillance, and
the metabolism of genotoxic compounds pose strong a priori
candidates, particularly given their established effects on mu-
tational signatures extracted from human cancers (Nik-Zainal
et al. 2012; Alexandrov et al. 2013). Among the 29 mouse
strains examined here, there are 845 segregating SNPs that
alter the amino acid sequence of genes with GO terms asso-
ciated with the maintenance of genome integrity, including
8 SNPs with predicted strongly deleterious effects (supple-
mentary table S7, Supplementary Material online). These lat-
ter variants present compelling targets for future
investigations.
Although the genetic drivers of mutation spectrum het-
erogeneity remain unknown, many of the causal variants
likely derive from the small, ancestral population of (mostly)
M. m. domesticus mice that provided the genetic source pool
for the laboratory inbred strains (Yang et al. 2007).
Evolutionary theory predicts considerable scope for segregat-
ing mutation modifiers in natural populations (Lynch 2008,
2010; Sung et al. 2012). Although reduced organismal muta-
tion rates are selectively favored in most scenarios (due to the
negative fitness consequences of accumulated deleterious
alleles), selection against weak mutation rate modifiers is in-
effective in small and modestly sized populations, where the
stochastic effects of genetic drift overwhelm the deterministic
forces of natural selection (Lynch 2010, 2011; Sung et al. 2012).
As a result, even moderate-strength modifiers of the muta-
tion spectrum are potentially long-lived in natural mamma-
lian populations and may rise to intermediate allele
frequencies. Consistent with this prediction, a recent analysis
of haplotype variation in humans reported the action of mul-
tiple historical mutation rate modifiers (Seoighe and Scally
2017). These considerations, combined with the large muta-
tional target size for the accumulation of genetic variance for
mutation, suggest the high likelihood of ancestrally derived
mutation modifiers segregating in inbred mouse strains.
Given that laboratory mice capture a limited subset of wild
mouse diversity, the magnitude of mutation rate variation in
wild populations is almost certainly far greater than that
summarized here.
At the same time, mutation modifiers may have also
emerged de novo in laboratory colonies. Consistent with
this possibility, there are 219 nonsynonymous and premature
stop variants in putative mutation modifier candidates that
are private to single strains (supplementary table S7,
Supplementary Material online).
Further, the efficacy of natural selection against even large-
effect mutation rate modifiers in laboratory colonies is likely
quite weak due to small effective population sizes and labo-
ratory housing conditions that potentially minimize the neg-
ative fitness consequences of deleterious alleles. Thus, both
ancestral and young alleles are likely to shape observed var-
iation in the mouse mutation spectrum, but further investi-
gation is required to determine their relative contributions.
Despite these theoretical arguments, there remains little
direct evidence for segregating modifiers of the de novo mu-
tation rate in mammalian populations (see Seoighe and Scally
2017 for a notable exception). Mutation rate variation among
Table 2. Spearman Correlations between Strain Reproductive Traits
and the Mutation Spectrum.
Dam Age at First Litter Interbirth Interval
Spearman’s
Rho
P value Spearman’s
Rho
P value
Principle
component 1
0.059 0.831 0.035 0.900
% C>A 20.026 0.926 20.421 0.106
% C>G 0.126 0.641 0.647 0.008
% nonCpG>T 0.018 0.952 20.244 0.361
%CpG>TpG 20.009 0.978 0.047 0.865
% T>A 0.279 0.294 0.303 0.253
% T>C 0.153 0.571 0.362 0.169
% T>G 20.203 0.450 0.050 0.857
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sequenced human trios can be explained almost entirely by
variation in parental age (Kong et al. 2012; Goldman et al.
2016; Jonsson et al. 2017). However, the absence of large-effect
modifiers of the mutation rate in human populations does
not preclude the possibility that loci that exert nuanced
effects on the mutation spectrum are segregating in our spe-
cies or present in mice (Harris and Pritchard 2017; Seoighe
and Scally 2017).
Conclusions
Here, I harnessed the unique history of laboratory mice in
conjunction with high-quality whole-genome sequences to
define SPV spectra in 29 common inbred mouse strains. I
documented significant strain variation in the relative prob-
ability of different mutational classes, including a strong mu-
tation dependency on local nucleotide context. I showed that
SPVs match neutral variant expectations and approximate
multidimensional properties of spontaneous germline muta-
tions in house mice. These considerations support the inter-
pretation of SPVs as recent de novo germline mutations. I
show that strain variation in age at reproduction cannot ex-
plain observed strain differences in the mutation spectrum,
demonstrating that the constellation of new mutations that
accumulate at a given generation is at least partially subject to
genetic control in house mice.
The finding that genetic background likely influences the
mutation spectrum raises the related question of whether
segregating variation also contributes to differences in the
overall de novo mutation rate among inbred mouse strains.
If so, it is of considerable interest to define the genetic archi-
tecture of this cellular phenotype, including identifying germ-
line mutation rate modifying genes. Toward this goal, it may
be possible to harness genomic resources from The
Collaborative Cross (Srivastava et al. 2017) and other recom-
binant inbred mouse populations to estimate the pace of
mutation accumulation in different genetic backgrounds
and map global mutation rate modifiers. Notably, the discov-
ery of mutation rate modifiers in mice could steer the search
for modifiers in human populations, where the confounding
effects of variable mutagen exposure and parental age are
likely to impede direct mapping efforts.
Materials and Methods
SNP Data and Annotation
Publicly available VCF files from the high-quality whole ge-
nome sequences of 29 inbred laboratory mouse strains were
downloaded from the Sanger Mouse Genomes project FTP
site (ftp://ftp-mouse.sanger.ac.uk/current_snps/; last accessed
on May 31, 2017). All genomes were sequenced to >12
coverage, with all but three sequenced to >30 coverage
(median coverage ¼ 43.76; supplementary table S3,
Supplementary Material online). Variants were identified rel-
ative to the GRCm38 reference assembly based on the C57BL/
6J inbred mouse strain. Variants were subsequently annotated
using snpEff (v4.3t; Cingolani et al. 2012) and intersected with
the phastCons60wayPlacental, genomicSuperDups, and
RepeatMasker tracks obtained from the UCSC Table
Browser (Kent et al. 2002).
The VCF file for 27 wild-caught M.m. domesticus mice was
obtained from a public repository (http://wwwuser.gwdg.de/
evolbio/evolgen/wildmouse/; last accessed June 2, 2017
Harr et al. 2016). Variants were filtered to include only biallelic
SNPs that pass all filters using VCFtools (Danecek et al. 2011).
De novo mutation data sets for cow (Harland C, Charlier C,
Karim L, Cambisano N, Deckers M, Mni M, Mullaart E,
Coppieters W, Georges M, unpublished data), human
(Jonsson et al. 2017), and mouse (Srivastava et al. 2017;
Lindsay et al. 2018) were obtained from the supplemental
materials of the associated publications.
Identification of Strain-Private Substitutions
Shared haplotypes were identified for each pair of laboratory
strains using GERMLINE (v1.5.1; Gusev et al. 2008). Briefly, this
program identifies genomic regions shared identical by de-
scent (IBD) over a specified minimum block size with a user-
defined tolerance for mismatches. Autosomal biallelic SNPs
with a minor allele frequency >0.05 across the 29 inbred
laboratory strains were used for the inference of IBD haplo-
types. A minimum block size of 200 kb and a cutoff of 0
mismatches were specified.
To relate the IBD block sizes in laboratory strains to those
found in wild populations, I identified IBD regions in a set of
27 wild-caught M. m. domesticus mice from four populations
in the native species range (Harr et al. 2016). The largest IBD
track found in wild M. m. domesticus populations was
4.78 Mb in length. To ensure a focus on IBD regions in the
laboratory strains that are shared by virtue of their descent
from a single founder animal, I restrict all analyses of muta-
tions in the laboratory strains to IBD regions spanning
5 Mb.
I then imposed a set of stringent filters to identify high-
quality, SPVs that reside on IBD haplotypes 5 Mb:
(1) The variant is present as either a heterozygous or fixed
singleton in 29 inbred laboratory strain genomes se-
quenced by the Sanger Mouse Genomes Project
(2) The variant passes all filters predefined in the Sanger
Mouse Genomes Project VCF file, with the exception
of the “Het” filter
(3) Variant is a biallelic SNP
(4) QUAL >50
(5) GQ >60
(6) DP >10 and DP <1.9 average sample coverage
(7) <15% missing data
(8) Site does not overlap segmental duplications anno-
tated in mm10
(9) Site is not repeat-masked
(10) Genotype likelihood difference >20 between the
most likely and next most likely genotype calls in
the strain harboring the putative SPV
(11) Site is not polymorphic in wild Mus musculus or Mus
spretus genomes (Harr et al. 2016) or present in wild-
derived inbred strain genomes (WSB/EiJ, LEWES/EiJ,
ZALENDE/EiJ, CAST/EiJ, MOLF/EiJ, PWK/PhJ, and
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SPRET/EiJ). This filter is imposed to eliminate ances-
tral variants, but will also remove sites of frequent
recurrent mutation (e.g., CpG dinucleotides).
(12) If the variant is heterozygous, allele balance ratio>0.3.
(13) If the variant is heterozygous, a v2 test on the null
hypothesis of no allele bias and no strand bias yields
P > 0.05
SPVs within IBD regions that passed these filters were then
polarized into ancestral and derived states under the assump-
tion that the major (i.e., nonprivate) allele is ancestral. The
nucleotides flanking either side of each strain-private variant
were extracted from the mm10 reference assembly and used
to partition sites into their trinucleotide contexts.
Identification of Common Mouse Variants
Common variants were defined as biallelic SNPs in the Sanger
Mouse Genomes data that are segregating in at least two
laboratory strains. Variants in repetitive regions and anno-
tated segmental duplications were excluded to match the
filtering criteria employed for the detection of SPVs. The likely
ancestral state at each site was defined using parsimony.
Briefly, I identified the subset of common laboratory strain
variants that are fixed for a single allele in the wild-derived
inbred strains PWK/PhJ (M. m. musculus), CAST/EiJ (M. m.
castaneus), and SPRET/EiJ (M. spretus). In these cases, the
ancestral state is inferred to be the allele present in the
wild-derived samples.
Strain Breeding Characteristics
Measures of strain breeding performance were obtained from
the JAX5 database (Currer et al. 2009) downloaded from the
Mouse Phenome Database (Bogue et al. 2018). One-way
ANOVA tests treating strain as a factor were used to test
for significant among-strain variation in measures related to
reproductive aging.
Statistical Analyses
All analyses were carried out in the R environment for statis-
tical computing (R Core Team 2016). Mutational spectra
were compared using G-tests of independence. Principle
component analysis was carried out on untransformed rela-
tive frequencies of six mutational classes (standardized by the
nucleotide content of IBD regions) using the prcomp func-
tion in R. Data were zero-centered and scaled to have unit
variance prior to analysis.
Supplementary Material
Supplementary data are available at Molecular Biology and
Evolution online.
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